Abbott Diabetes Care
Lingo tracks glucose in real time and delivers personal insights and coaching.
The funds raised will be used for geographical expansion and to improve their biomarker technology.
The system is able to continuously transmit glucose data every minute.
A diabetes startup that uses artificial intelligence, Bigfoot Biomedical, has just announced that it scored a total of $55 million in Series B equity financing with new investments from Abbott and other existing funders.